brofaromine has been researched along with Depression in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lotufo-Neto, F; Thase, ME; Trivedi, M | 1 |
Fritze, J; Lanczik, M; Pfüller, H; Riederer, P; Sofic, E | 1 |
1 review(s) available for brofaromine and Depression
Article | Year |
---|---|
Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Topics: Benzamides; Controlled Clinical Trials as Topic; Depression; Humans; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Treatment Outcome | 1999 |
1 trial(s) available for brofaromine and Depression
Article | Year |
---|---|
Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine.
Topics: Adult; Blood Glucose; Depression; Double-Blind Method; Humans; Hydrocortisone; Male; Monoamine Oxidase Inhibitors; Parasympathetic Nervous System; Physostigmine; Piperidines; Scopolamine; Sympathetic Nervous System; Synaptic Transmission | 1990 |